Lupin Limited has informed the Exchange about press release dated 29-Aug-2022 titled Lupin Receives Tentative Approval from U.S. FDA for Dasatinib Tablets.
Lupin Limited has informed the Exchange about press release dated 29-Aug-2022 titled Lupin Receives Tentative Approval from U.S. FDA for Dasatinib Tablets.